EASL Clinical Practice Guidelines: Drug-induced liver injury.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:.
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK, Björnsson ES.
Eur J Intern Med. 2022 Mar;97:26-31. doi: 10.1016/j.ejim.2021.10.035. Epub 2021 Nov 9.
Drug-induced liver injury.
Katarey D, Verma S.
Clin Med (Lond). 2016 Dec;16(Suppl 6):s104-s109. doi: 10.7861/clinmedicine.16-6-s104.
Biomarkers of drug-induced liver injury.
McGill MR, Jaeschke H.
Adv Pharmacol. 2019;85:221-239. doi: 10.1016/bs.apha.2019.02.001. Epub 2019 Mar 6.
Drug-induced liver injury.
Kumachev A, Wu PE.
CMAJ. 2021 Mar 1;193(9):E310. doi: 10.1503/cmaj.202026.
RUCAM in Drug and Herb Induced Liver Injury: The Update.
Danan G, Teschke R.
Int J Mol Sci. 2015 Dec 24;17(1):14. doi: 10.3390/ijms17010014.
Drug-Induced Liver Injury.
Fisher K, Vuppalanchi R, Saxena R.
Arch Pathol Lab Med. 2015 Jul;139(7):876-87. doi: 10.5858/arpa.2014-0214-RA.
Drug-Induced Liver Injury After Liver Transplantation.
Jiménez-Pérez M, González-Grande R, García-Cortés M, Andrade RJ.
Liver Transpl. 2020 Sep;26(9):1167-1176. doi: 10.1002/lt.25804.
Signatures in drug-induced liver injury.
Tillmann HL, Rockey DC.
Curr Opin Gastroenterol. 2020 May;36(3):199-205. doi: 10.1097/MOG.0000000000000636.
Drug-Induced Liver Injury in the Setting of Analgesic Use.
Darr U, Sussman NL.
Clin Liver Dis. 2020 Feb;24(1):121-129. doi: 10.1016/j.cld.2019.09.008. Epub 2019 Nov 1.
